3D printing of living tissue advances with first lab shipment
3D or bioprinted organs may be years away, but 'liver strips' are now shipping for drug toxicity testing in the lab
New adverse-events reporting service speeds results to payers
Adverse Events, Inc., finds a receptive client base among managed-care providers
McKesson succeeds in new effort to acquire Celesio
Bondholder sale brings McKesson its desired >75% ownership of the European wholesaler
An app for specialty pharmacy
New-media venture could challenge existing pharmacy benefit-verification processes for specialties
AbbVie enters Asian manufacturing with a $320-million site in Singapore
Facility will produce both biologics and small molecules
NIH takes the wraps off the Accelerating Medicines Partnership
Five-year, $230-million effort targets diseases through public-private partnership
United Drug solidifies its Ashfield pharma-services businesses globally
Reorganization is hoped to raise profile of company's contract-sales, patient-support and related services
Tim Wentworth is new Express Scripts president
Company's integration of Medco is 'largely complete'
Cargo theft of pharmaceuticals continues to fall in the US
Risk in other parts of the world remain higher and may be rising
'Dragon's blood' used to treat chemo-induced diarrhea is slotted for dogs undergoing cancer treatment
Developer Napo Pharma/Jaguar Animal Health sees parallels in human and animal therapies
Walgreens combines operations with CareMetx to address specialty-patient hub services
Walgreens' Pharma Dynamics subsidiary will be merged into CareMetx
Full-line distributor sales topped $300 billion in 2012, representing 91% of pharma sales
HDMA's 2013-14 Factbook updates member financial, operational performance
Cold Chain Technologies upgrades materials, insulation for temperature-controlled packaging
New KoolTemp GTS parcels have higher performance and lower cost and weight
Industry group Rx-360 lays plans for expanding activities in China
An inaugural planning meeting was held in November; meanwhile China cracks down on online sales
Consulting firm puts compliance front and center for clinical-stage drug developers
New 'emergent biopharma' service combines compliance with pricing, market access
QPharma offers QLaunch advisory service
Formulary exclusion—the ultimate revenge?
Bad air: air carriers wrestle with dry ice concerns
IMS Institute assesses social media for industry significance
J&J is the far-and-away leader in the IMS Health Social Media Engagement Index
FDA Mini-Sentinel project exceeds its goals, but future is uncertain
Effort to use health records to detect 'safety signals' will connect to other national programs: here comes IMEDS
Reactions are muted to FDA's social-media guidance
Besides common-sense monitoring of social media activity by pharma, FDA will exercise 'enforcement discretion' in reviewing online activities
FDA approved 27 new drugs in 2013
Agency lauds itself on speedy reviews, but others keep pressure on
Educating patients on self-administered drug injections
The trend toward self-administered drugs creates a pressing need for better patient-education resources
A conversation with Peyton Howell, AmerisourceBergen
Top health industry issues for life sciences in 2014
PwC's annual forecast of the year's most important healthcare trends
Networking for life science logistics
The Health & Personal Care Logistics Conference brings industry leaders together
DQSA: a bargain for the life sciences industry
The Drug Quality and Security Act will change industry for the better
HDMA looks closely at 'buy and bill' in specialty pharma distribution
Will 'white bagging' and specialty-pharmacy business practices change distribution dynamics?
IMS Institute projects global pharma market of $1.17-1.20 trillion in 2017
Growth includes 1-4% CAGR in US, 0-3% in Europe and 14-17% in China. US specialties have a twist
Contract administration software market heats up with new offerings
Both Revitas and Model N bring out enhanced script-validation modules to ensure rebate accuracy
